2-(Chloromethyl)-4-methylquinazoline: Your Key Linagliptin Intermediate

Unlock advancements in diabetes treatment with our high-purity pharmaceutical intermediate.

Get a Quote & Sample

Advantages Provided by the Product

Enhanced Drug Synthesis Efficiency

Utilizing this key intermediate streamlines the linagliptin synthesis pathway, reducing production time and costs for pharmaceutical companies.

Facilitates Drug Discovery

As a versatile organic reagent for research, it enables medicinal chemists to explore novel quinazoline derivatives, accelerating drug discovery efforts.

Guaranteed Quality and Purity

With rigorous quality control, including assays up to 99% by HPLC, this product ensures the integrity and efficacy of the final pharmaceutical product.

Key Applications

Linagliptin Manufacturing

Serves as a fundamental component in the large-scale production of Linagliptin, a vital medication for managing type 2 diabetes.

Pharmaceutical Research & Development

Acts as a valuable building block for scientists investigating new therapeutic agents and exploring novel synthetic routes.

Custom Synthesis Projects

Its reactive chloromethyl group makes it ideal for bespoke synthesis of complex organic molecules and quinazoline-based compounds.

Quality Control Standards

Used in analytical laboratories to develop and validate quality control methods for pharmaceutical intermediates and APIs.

Why Choose Us?

Leverage our expertise and state-of-the-art infrastructure to accelerate your journey from discovery to commercial success.

Global Experience

With 20 years of R&D, manufacturing, and sales experience, we proudly serve clients across 60 countries and regions worldwide.

Advanced Facilities

Our in-house R&D laboratory, pilot platform, and large-scale production workshop are equipped to meet the audit requirements of global customers.

Seamless Scalability

We facilitate a perfect transition from small-scale lab requirements (grams) to full commercialization (hundreds of tons).